How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AN

NYSE:ANVS
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AN

Annovis Bio IncNYSE ANVS Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNYS - New York Stock Exchange, Inc

FAIR VALUE

Is ANVS undervalued compared to its fair value?

The fair value of ANVS stock is hidden USD. Relative to the market price of 10.75 USD Annovis Bio Inc is hidden.

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The company is headquartered in Berwyn, Pennsylvania and currently employs 3 full-time employees. The company ...[More about valuation]

Annovis Bio Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.127 $B

Price:

10.75 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-1.634

FINANCIALS

Annovis Bio financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.01 B
0.0067 B

Financial Position Analysis

Assets

0.01 B
Current Assets
0.01 B
Total non-current assets

Total current liabilities
0.0036 B
Total non-current liabilities

Cash Flow Statement

-0.0094 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0094 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Annovis Bio fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ANVS attractive for investment based on fundamental analysis?

ANVS stock rating is hidden. Annovis Bio is a hidden by Eyestock methodology.

Get ANVS Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ANVS analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ANVS to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Annovis Bio Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Annovis Bio Inc dividends

ANVS dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ANVS stock

About the company Annovis Bio Inc

Market cap $B

0.127

Dividend yield

Shares outstanding

8.16392 B

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The company is headquartered in Berwyn, Pennsylvania and currently employs 3 full-time employees. The company went IPO on 2020-01-29. The firm is engaged in developing treatments for neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s disease in Down syndrome (AD-DS). The firm's lead compound, Buntanetap, is an orally administered drug being developed for chronic indications such as AD, PD and AD-DS. The firm's ANVS405 compound is being developed for acute indications, focused on protecting the brain after Traumatic brain injury (TBI) and/or stroke. Its ANVS405 is the same compound as Buntanetap, but it is given intravenously in cases of acute head and brain trauma. The firm is also developing its compound, ANVS301 to increase cognitive capability in later stages of AD and dementia.

ANVS profile

  • Ticker

    ANVS

  • Country

    USA

  • Exchange

    XNYS - New York Stock Exchange, Inc

  • Report currency

    USD - US dollar

  • IPO date

    29 January 2020

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    3

  • City

    Berwyn

  • Address

    1055 Westlakes Dr Ste 300

  • Cusip

    03615A108